FX.co ★ Stock markets in the US gained back losses, while Europe and Asia moved multidirectional

The US stock exchanges ended on a good note on Monday. The main stock indicators were able to significantly increase their positions, which allowed them to even offset most of the losses that occurred earlier. The reason for the positive was the progress in the development of a vaccine against coronavirus infection. Recall that clinical trials were abruptly interrupted due to problems. In addition, there was an increase in activity in the mergers and acquisitions sector, which also had a positive impact on the mood of market participants and the level of indices.

The Dow Jones Industrial Average rose 1.18% or 327.69 points. Its current level has moved to the level of 27,993.33 points. During the trading day, it crossed the important level of 28,000 points several times.

The S&P 500 index gained 1.27% or 42.57 points, which sent it to 3,383. 54 points.

The Nasdaq Composite index was the leader of Monday's growth which immediately added 1.87% or 203.11 points. This allowed it to reach 11,056. 65 points.

Overall, the Dow Jones lost 1.7% and the S&P 500 lost 2.5% over the past week, ended September 11. However, the Nasdaq Composite index recorded the most significant fall at 4.1%, which was its highest weekly drop in almost five months.

The American stock market began to experience significant support on news related to company transactions, including mergers and acquisitions. Investors were very encouraged by the plans for close cooperation between Oracle Corp. from America and ByteDance Ltd. from China. This partnership is particularly important in connection with the ongoing conflict between Washington and Beijing.

In addition, the news of the resumption of clinical trials of a vaccine against coronavirus infection, which is being jointly developed by the pharmaceutical company AstraZeneca and the University of Oxford, had a very positive effect on market sentiment. Recall that at the beginning of September, trials had to be paused due to an unexpected side effect that occurred in one of the volunteer patients. New permission to continue the study was only obtained after the UK's Medicines and Healthcare Products FDA approved a safety review. Immediately thereafter, AstraZeneca stock went up and gained 0.5%.

The company Pfizer, which is also actively developing its own vaccine against COVID-19, has already announced that by the end of next month all the results on the effectiveness of the new drug will be known, and by the end of this year, it can be launched into mass production.

However, there is still no complete and clear picture of the coronavirus vaccine, which leaves most of the market participants uncertain about this. Moreover, investors began to realize that the release of a new drug is a long process, and one should not hope for an instant result. Of course, all this somewhat limits the work of traders.

The US Federal Reserve System is scheduled to conduct a meeting this week, which may significantly impact market activity. The Bank of England and the Bank of Japan also scheduled meetings where issues that are quite acute for stock markets will be raised.

Meanwhile, Asian stocks traded irresolute on Tuesday as main exchange indicators could not determine a uniform dynamics and showed multidirectional movement: some reduced their positions, others actively increased.

Japan's Nikkei 225 index fell 0.44%.

China's Shanghai Composite index, on the contrary, was marked by a growth of 0.27%. The Hong Kong Hang Seng Index continued its positive trend and gained 0.38%. Market participants here were pleasantly surprised by the good statistics that started coming on Monday. The level of economic activity in the state has grown rapidly over the last month of the summer, which was caused by the next incentives from the government. The level of retail sales in China increased by 0.5%. Initial forecasts assumed an increase of no more than 0.1%. Note that in the second month of summer, this indicator decreased significantly by 1.1%.

The level of industrial production in the country also rose 5.6% on an annualized basis. This increase was the fifth in a row. The unemployment rate over the last month of summer, on the contrary, fell to 5.6% which was previously at 5.7%.

The number of investments in fixed assets of the state from January to August also decreased by 0.3% compared to the same period a year earlier. Nevertheless, there are still more reasons for enthusiasm in China.

South Korea's Kospi Index was up 0.58%.

The Australian S & P / ASX 200 index, on the contrary, reduced its positions by 0.15%.

European stock exchanges also recorded multidirectional movements. The main stock indicators moved extremely uncertain and weak. This was mainly due to the anticipation of the meeting of the US Federal Reserve and its continuation of the dovish policy adopted earlier.

The general index of large enterprises in the Stoxx Europe 600 region slightly went up by 0.07%, and its current indicator level was around 368.75 points.

The UK FTSE 100 Index gained 0.15%. The German DAX index, on the other hand, fell 0.29%. France's CAC 40 index also went down by 0.19%. Italy's FTSE MIB Index sank 0.21%. Spain's IBEX 35 index was up 0.53%.